These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression. Hounoki H; Sugiyama E; Mohamed SG; Shinoda K; Taki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Miyahara T Bone; 2008 Apr; 42(4):765-74. PubMed ID: 18242157 [TBL] [Abstract][Full Text] [Related]
48. Differential regulation of chemokine gene expression by 15-deoxy-delta 12,14 prostaglandin J2. Zhang X; Wang JM; Gong WH; Mukaida N; Young HA J Immunol; 2001 Jun; 166(12):7104-11. PubMed ID: 11390455 [TBL] [Abstract][Full Text] [Related]
49. Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2. Petrova TV; Akama KT; Van Eldik LJ Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4668-73. PubMed ID: 10200320 [TBL] [Abstract][Full Text] [Related]
50. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2. Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591 [TBL] [Abstract][Full Text] [Related]
51. Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-gamma: effect of 15-deoxy-Delta(12,14)-PGJ(2) and troglitazone. Lappas M; Permezel M; Georgiou HM; Rice GE J Clin Endocrinol Metab; 2002 Oct; 87(10):4667-72. PubMed ID: 12364456 [TBL] [Abstract][Full Text] [Related]
53. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes. Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742 [TBL] [Abstract][Full Text] [Related]
54. Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta12,14-prostaglandin J2. Butler R; Mitchell SH; Tindall DJ; Young CY Cell Growth Differ; 2000 Jan; 11(1):49-61. PubMed ID: 10672903 [TBL] [Abstract][Full Text] [Related]
55. Selective inhibition of cyclooxygenase-2 expression by 15-deoxy-Delta(12,14)(12,14)-prostaglandin J(2) in activated human astrocytes, but not in human brain macrophages. Janabi N J Immunol; 2002 May; 168(9):4747-55. PubMed ID: 11971025 [TBL] [Abstract][Full Text] [Related]
56. PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells. Goetze S; Xi XP; Kawano H; Gotlibowski T; Fleck E; Hsueh WA; Law RE J Cardiovasc Pharmacol; 1999 May; 33(5):798-806. PubMed ID: 10226869 [TBL] [Abstract][Full Text] [Related]
57. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Chinetti G; Fruchart JC; Staels B Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900 [TBL] [Abstract][Full Text] [Related]
58. 15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts. Lin TH; Tang CH; Wu K; Fong YC; Yang RS; Fu WM J Cell Physiol; 2011 Dec; 226(12):3242-50. PubMed ID: 21344384 [TBL] [Abstract][Full Text] [Related]
59. Peroxisome proliferator-activated receptors, orphans with ligands and functions. Schoonjans K; Martin G; Staels B; Auwerx J Curr Opin Lipidol; 1997 Jun; 8(3):159-66. PubMed ID: 9211064 [TBL] [Abstract][Full Text] [Related]